Jason Rando | Investor Relations, Tiberend Strategic Advisors, Inc. |
Travis Mickle | President & Chief Executive Officer |
LaDuane Clifton | Chief Financial Officer |
Rusty Johnson | Chief Business Officer |
Dan Busby | RBC Capital Markets |
Scott Henry | Roth Capital Partners |
Good day, ladies and gentlemen, and welcome to the KemPharm Fourth Quarter and Year End 2018 Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this call is being recorded. I would now like to introduce your host for today's conference Mr.